http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003147872-A1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-6056 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55555 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-5158 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-001 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-18 |
| filingDate | 2003-01-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7a15fbbe048896dc6daf1bdff5c1245a |
| publicationDate | 2003-08-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-2003147872-A1 |
| titleOfInvention | Immunosuppressant |
| abstract | The present invention relates to an immunosuppressant comprising antigen-treated B lymphocytes obtained by contact-treating B lymphocytes with an antigen, a liposome encapsulating or attaching to itself an antigen, or a conjugate of an antigen and a substance which binds to B lymphocytes, or a mixture of at least two of these substances. The present invention also relates to such liposomes and conjugates. The present invention also relates to a method for creating an immunosuppressed animal comprising transferring the immunosuppressant to an animal, and to an immunosuppressed animal created by such methods. The present invention further relates to a method for treating or preventing diseases comprising administering the immunosuppressant to a human. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005214758-A1 |
| priorityDate | 1995-04-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 322.